Australian research company buys OP facility to create U.S. footprint

An Australia-based global clinical research organization will create its U.S. foothold by acquiring Vector Oncology's Pharma Services division in Overland Park. Vector Oncology’s scientific trials and medical operations are based in Memphis, but its Pharma Services division is in Overland Park. The acquisition will bring Vector Oncology’s trial delivery solutions to the Asia-Pacific region, while expanding George Clinical’s expertise in vascular, re nal respiratory diseases and neurology in…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news